20:1.0.1.3.4.3.124 | SUBJGRP 124
| General Provisions | |
20:1.0.1.3.4.3.124.1 | SECTION 30.200
| 30.200 What is the scope of this subpart | |
20:1.0.1.3.4.3.125 | SUBJGRP 125
| Eligibility Criteria for Claims Relating to Covered Beryllium Illness Under Part B of EEOICPA | |
20:1.0.1.3.4.3.125.2 | SECTION 30.205
| 30.205 What are the criteria for eligibility for benefits relating to beryllium illnesses covered under Part B of EEOICPA | |
20:1.0.1.3.4.3.125.3 | SECTION 30.206
| 30.206 How does a claimant prove that the employee was a “covered beryllium employee” exposed to beryllium dust, particles or vapor in the performance of duty | |
20:1.0.1.3.4.3.125.4 | SECTION 30.207
| 30.207 How does a claimant prove a diagnosis of a beryllium disease covered under Part B | |
20:1.0.1.3.4.3.126 | SUBJGRP 126
| Eligibility Criteria for Claims Relating to Radiogenic Cancer Under Parts B and E of EEOICPA | |
20:1.0.1.3.4.3.126.5 | SECTION 30.210
| 30.210 What are the criteria for eligibility for benefits relating to radiogenic cancer | |
20:1.0.1.3.4.3.126.6 | SECTION 30.211
| 30.211 How does a claimant establish that the employee has or had contracted cancer | |
20:1.0.1.3.4.3.126.7 | SECTION 30.212
| 30.212 How does a claimant establish that the employee contracted cancer after beginning employment at a DOE facility, an atomic weapons employer facility or a RECA section 5 facility | |
20:1.0.1.3.4.3.126.8 | SECTION 30.213
| 30.213 How does a claimant establish that the radiogenic cancer was at least as likely as not related to employment at the DOE facility, the atomic weapons employer facility, or the RECA section 5 facility | |
20:1.0.1.3.4.3.126.9 | SECTION 30.214
| 30.214 How does a claimant establish that the employee is a member of the Special Exposure Cohort | |
20:1.0.1.3.4.3.126.10 | SECTION 30.215
| 30.215 How does a claimant establish that the employee has sustained an injury, illness, impairment or disease as a consequence of a diagnosed cancer | |
20:1.0.1.3.4.3.127 | SUBJGRP 127
| Eligibility Criteria for Claims Relating to Chronic Silicosis Under Part B of EEOICPA | |
20:1.0.1.3.4.3.127.11 | SECTION 30.220
| 30.220 What are the criteria for eligibility for benefits relating to chronic silicosis | |
20:1.0.1.3.4.3.127.12 | SECTION 30.221
| 30.221 How does a claimant prove exposure to silica in the performance of duty | |
20:1.0.1.3.4.3.127.13 | SECTION 30.222
| 30.222 How does a claimant establish that the employee has been diagnosed with chronic silicosis or has sustained a consequential injury, illness, impairment or disease | |
20:1.0.1.3.4.3.128 | SUBJGRP 128
| Eligibility Criteria for Certain Uranium Employees Under Part B of EEOICPA | |
20:1.0.1.3.4.3.128.14 | SECTION 30.225
| 30.225 What are the criteria for eligibility for benefits under Part B of EEOICPA for certain uranium employees | |
20:1.0.1.3.4.3.128.15 | SECTION 30.226
| 30.226 How does a claimant establish that a covered uranium employee has sustained a consequential injury, illness, impairment or disease | |
20:1.0.1.3.4.3.129 | SUBJGRP 129
| Eligibility Criteria for Other Claims Under Part E of EEOICPA | |
20:1.0.1.3.4.3.129.16 | SECTION 30.230
| 30.230 What are the criteria necessary to establish that an employee contracted a covered illness under Part E of EEOICPA | |
20:1.0.1.3.4.3.129.17 | SECTION 30.231
| 30.231 How does a claimant prove employment-related exposure to a toxic substance at a DOE facility or a RECA section 5 facility | |
20:1.0.1.3.4.3.129.18 | SECTION 30.232
| 30.232 How does a claimant establish that the employee has been diagnosed with a covered illness, or sustained an injury, illness, impairment or disease as a consequence of a covered illness | |